Alteration in miRNAs expression in paediatric acute lymphocyticleukaemia: Insight into patients' therapeutic response
- 20 July 2020
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 48 (1) , 35-43
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- MiR-24 Promotes the Survival of Hematopoietic CellsPLOS ONE, 2013
- Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancerJournal of Cancer Research and Clinical Oncology, 2012
- A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)Nature Genetics, 2011
- MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancerCell Death & Differentiation, 2011
- IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2010
- MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site PolymorphismPLOS ONE, 2009
- MicroRNA Patterns Associated with Clinical Prognostic Parameters and CNS Relapse Prediction in Pediatric Acute LeukemiaPLOS ONE, 2009
- Karyotype-specific microRNA signature in chronic lymphocytic leukemiaBlood, 2009
- Characterization of B‐ and T‐lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profilesGenes, Chromosomes and Cancer, 2009
- miR-24 Inhibits Cell Proliferation by Targeting E2F2, MYC, and Other Cell-Cycle Genes via Binding to “Seedless” 3′UTR MicroRNA Recognition ElementsMolecular Cell, 2009